p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
about
Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer.Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.Alcohol and Cancer Stem Cells.Protein Kinase Targets in Breast Cancer.The K-Ras effector p38γ MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation.
P2860
p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@ast
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@en
type
label
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@ast
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@en
prefLabel
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@ast
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@en
P2093
P2860
P356
P1433
P1476
p38γ MAPK Is a Therapeutic Tar ...... ncer Stem-Like Cell Expansion.
@en
P2093
Adrienne Lepp
Bryon Johnson
Christopher R Chitambar
Michael B Dwinell
Weiqing Jing
Xiaomei Qi
P2860
P304
P356
10.1002/STEM.2068
P577
2015-06-15T00:00:00Z